PROGRESSION-FREE SURVIVAL AND POSTPROGRESSION SURVIVAL IN PATIENTS WITH ADVANCED GASTRIC CANCER TREATED WITH FIRST-LINE CHEMOTHERAPY

被引：0
|
作者：
Shitara, K. [1 ]
Matsuo, K. [2 ]
Muro, K. [3 ]
Ohtsu, A. [1 ]
机构：
[1] East Hosp, Natl Canc Ctr, Kashiwa, Chiba, Japan
[2] Aichi Canc Ctr, Res Inst, Nagoya, Aichi 464, Japan
[3] Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：232 / 232
页数：1
相关论文
共 50 条
  • [1] Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy
    Shitara, Kohei
    Matsuo, Keitaro
    Muro, Kei
    Doi, Toshihiko
    Ohtsu, Atsushi
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (08) : 1383 - 1389
  • [2] Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy
    Kohei Shitara
    Keitaro Matsuo
    Kei Muro
    Toshihiko Doi
    Atsushi Ohtsu
    [J]. Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1383 - 1389
  • [3] POSTPROGRESSION SURVIVAL FOR FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED GASTRIC CANCER
    Kawakami, H.
    Okamoto, I.
    Hayashi, H.
    Taguri, M.
    Morita, S.
    Nakagawa, K.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 95 - 95
  • [4] Postprogression survival for first-line chemotherapy in patients with advanced gastric cancer
    Kawakami, Hisato
    Okamoto, Isamu
    Hayashi, Hidetoshi
    Taguri, Masataka
    Morita, Satoshi
    Nakagawa, Kazuhiko
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (14) : 3003 - 3009
  • [5] Low ATM expression and progression-free and overall survival in advanced gastric cancer patients treated with first-line XELOX chemotherapy
    Klempner, Samuel J.
    Bhangoo, Munveer S.
    Luu, Hubert Y.
    Kim, Seung Tae
    Chao, Joseph
    Kim, Kyoung-Mee
    Lee, Jeeyun
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (06) : 1198 - +
  • [6] Progression-free survival in first-line chemotherapy is a prognostic factor in second-line chemotherapy in patients with advanced gastric cancer
    Kenji Hashimoto
    Atsuo Takashima
    Kengo Nagashima
    Shun-suke Okazaki
    Takako Eguchi Nakajima
    Ken Kato
    Tetsuya Hamaguchi
    Yasuhide Yamada
    Yasuhiro Shimada
    [J]. Journal of Cancer Research and Clinical Oncology, 2010, 136 : 1059 - 1064
  • [7] Progression-free survival in first-line chemotherapy is a prognostic factor in second-line chemotherapy in patients with advanced gastric cancer
    Hashimoto, Kenji
    Takashima, Atsuo
    Nagashima, Kengo
    Okazaki, Shun-suke
    Nakajima, Takako Eguchi
    Kato, Ken
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Shimada, Yasuhiro
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (07) : 1059 - 1064
  • [8] Progression-free survival as a surrogate for overall survival in first-line chemotherapy for advanced pancreatic cancer
    Hamada, Tsuyoshi
    Nakai, Yousuke
    Isayama, Hiroyuki
    Yasunaga, Hideo
    Matsui, Hiroki
    Takahara, Naminatsu
    Mizuno, Suguru
    Kogure, Hirofumi
    Matsubara, Saburo
    Yamamoto, Natsuyo
    Tada, Minoru
    Koike, Kazuhiko
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 65 : 11 - 20
  • [9] Analysis of factors affecting progression-free survival of first-line chemotherapy in older patients with advanced gastrointestinal cancer
    Nakazawa, Junichi
    Kawahira, Machiko
    Kawahira, Masahiro
    Kodama, Tomoko
    Arima, Shiho
    Iwashita, Yuji
    Mawatari, Seiji
    Hashimoto, Shinichi
    Kanmura, Shuji
    Hori, Takeshi
    Tsubouchi, Hirohito
    Ido, Akio
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2021, 12 (08) : 1200 - 1207
  • [10] Real world progression-free survival in patients with advanced or metastatic urothelial cancer treated with first-line platinum-based chemotherapy
    Nikolaidis, Christos
    Li, Chen
    Lee, Chooi
    Mecke, Almut
    Reyes-Rivera, Irmarie
    Schroder, Carsten
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 319 - 319
12345